Kenneth R. Chien MD, Ph.D. is a Distinguished Professor of the Swedish Research Council at the Karolinska Institutet (KI) in Stockholm and a Co-Founder of Moderna Therapeutics. Over the past four decades, he has served as a senior advisor/Board Member in biotechnology, (e.g., Genentech, Roche, AZ, GSK, Wyeth, Pictet Biotech Fund, EQT Private Equity-Life Sciences, and Pfizer), and was a Co-Founder of the Institute of Molecular Medicine at Peking U. Kenneth, a 3rd generation Harvard alumnus, formerly was the Sanders Chair in Stem Cell and Regenerative Biology at Harvard before receiving a Presidential Appointment to KI. For his work on heart development and regeneration, he has received several awards, including membership in the Austrian and Norwegian Academy of Sciences, the Walter B Cannon Award of the American Physiological Society, The Pasarow Award, and an honorary Doctorate from the University of Edinburgh.
The healthcare panel will discuss challenges and opportunities in life-saving technology with experts, executives, and investors. Topics include post-pandemic issues and industry changes.